Getagraph.com logo
S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

Aktualne aktualizacje dla Egetis Therapeutics AB [EGTX.ST]

Giełda: STO Sektor: Healthcare Branża: Biotechnology
Upcoming Earnings Alert

5 days till quarter result
(bmo 2024-05-02)

Expected move: +/- 0.00%

Ostatnio aktualizowano26 bal. 2024 @ 18:29
25% discount on Stockinvest.us - Use code: Podcast

-3.20% SEK 5.75

Live Chart Being Loaded With Signals

Commentary (26 bal. 2024 @ 18:29):

Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment...

Stats
Dzisiejszy wolumen 568 552
Średni wolumen 344 445
Kapitalizacja rynkowa 1.68B
EPS SEK0 ( 2024-02-21 )
Następna data zysków ( SEK-0.310 ) 2024-05-02
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -4.42
ATR14 SEK0.0250 (0.43%)

Wolumen Korelacja

Długi: 0.28 (neutral)
Krótki: 0.60 (weak)
Signal:(59.783) Neutral

Egetis Therapeutics AB Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Egetis Therapeutics AB Korelacja - Waluta/Towar

The country flag -0.45
( neutral )
The country flag -0.31
( neutral )
The country flag 0.00
( neutral )
The country flag -0.37
( neutral )
The country flag -0.10
( neutral )
The country flag 0.71
( moderate )

Egetis Therapeutics AB Finanse

Annual 2023
Przychody: SEK57.60M
Zysk brutto: SEK-126.80M (-220.14 %)
EPS: SEK-1.270
FY 2023
Przychody: SEK57.60M
Zysk brutto: SEK-126.80M (-220.14 %)
EPS: SEK-1.270
FY 2023
Przychody: SEK0
Zysk brutto: SEK0 (0.00 %)
EPS: SEK0
FY 2022
Przychody: SEK22.50M
Zysk brutto: SEK-120.10M (-533.78 %)
EPS: SEK-0.980

Financial Reports:

No articles found.

Egetis Therapeutics AB

Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej